6
Registered beds
Cumbria care home
Fairmead House
A 6-bed residential care home in Kendal, operated by Elysium Healthcare (Ann House) Limited. The numbers, the CQC rating and the finance to buy, refinance or develop a home like it.
Written and reviewed by Matt Lenzie Founder & Principal Broker · 25 years arranging care home finance · Reviewed June 2026
Residential
Registration type
Good
CQC rating (29/05/2021)
£366k
Indicative value
Fairmead House is a 6-bed residential care home in Kendal, operated by Elysium Healthcare (Ann House) Limited. It holds a CQC rating of Good, a solid CQC rating that supports mainstream lending appetite. For a buyer, operator or lender the numbers that matter are its 6 registered beds, its rating and the strength of the operator behind it. We arrange the finance to buy, refinance or develop a home of this kind.
Fairmead House sits within a local market of 14 registered care homes and about 469 beds in Kendal. That competitive set, and the rating profile across it, is part of how an acquisition here is underwritten.
Financing a home like Fairmead House
Whether you are acquiring Fairmead House, refinancing it onto better terms, or funding works, the facility is structured on the operator covenant, the CQC rating, occupancy and the fee mix. A commercial mortgage typically funds 70 to 75 percent of value over 15 to 25 years; going-concern operator finance is sized on EBITDARM; bridging covers a fast purchase or a pre-CQC period. We place the case with the lenders that back residential homes of this profile.
On an indicative basis a 6-bed home values at around £366k using an England average of about £61k per bed (LaingBuisson, a Fair Cost of Care valuation basis, not a transaction price). A trading care home is actually valued on its stabilised profit and going-concern value by a specialist healthcare valuer, so the real figure turns on occupancy, fee mix and the operator. As a rough guide a lender might advance up to about £256k against a home of this size and rating, sized on trading profit rather than bricks.
This home at a glance
| Registered beds | 6 |
| Type | Residential |
| CQC rating | Good |
| Operator | Elysium Healthcare (Ann House) Limited |
| Indicative value | £366k |
| Indicative debt (70%) | £256k |
Indicative figures on a per-bed basis, not a valuation or an offer of finance.
Registered specialisms
- Caring for adults under 65 yrs
- Learning disabilities
- Mental health conditions
- Caring for adults over 65 yrs
- Physical disabilities
What determines the value of Fairmead House
A trading care home like Fairmead House is valued as a going concern, on its stabilised trading profit (EBITDARM) capitalised at a market multiple, rather than as bricks and mortar. A specialist healthcare valuer prepares the figure, and it can sit well above or below a simple per-bed estimate depending on how the home trades. The per-bed guide above is a starting point, not a valuation.
- Occupancy: how full the home runs, and how quickly empty beds refill
- Fee mix: the balance of private, self-funded and local-authority residents
- CQC rating: Good here, a direct input to both value and lender appetite
- Staffing: care-hours per resident and agency reliance
- The building: room sizes, the en-suite and single-room share, and any capital works needed
- Location and catchment: local demand, competition and the self-funder base around Kendal
Looking at other homes in the area? See care homes in Kendal and the wider Cumbria care market or Elysium Healthcare (Ann House) Limited's full portfolio.
Other care homes in Kendal
- Kendal Care Home 120 beds, Good
- Heron Hill Care Home 86 beds, Good
- Summerhill Care Home 71 beds, Good
- Gilling Reane Care Home 33 beds, Good
- Riverside House 32 beds, Good
More homes operated by Elysium Healthcare (Ann House) Limited
- Ann House Kendal
- 39a Castle Road Kendal
FAQ
Financing Fairmead House: common questions
How is Fairmead House valued?
On its stabilised trading profit and going-concern value, assessed by a specialist healthcare valuer, not on a per-bed rule of thumb. Occupancy, the fee mix, the CQC rating (currently Good) and staffing cost all feed the figure. Send us the trading accounts and we will give a view on value and what a lender would advance.
What should I check before buying Fairmead House?
The things that move value and fundability: the CQC rating and inspection history, occupancy and how fast beds refill, the fee mix, agency-staffing reliance, the building condition and en-suite provision, and the trading accounts behind the price. We pressure-test these as part of arranging the finance.
How much would it cost to buy a home like Fairmead House?
On an indicative £61k-per-bed basis a 6-bed home is in the region of £366k, but a trading care home is valued on its stabilised profit and going-concern value, not a per-bed rule of thumb. The real price turns on occupancy, the fee mix and the operator. We can give a fundability view once we see the trading figures.
Can I get finance to buy Fairmead House?
Most lenders fund up to 70 to 75 percent of value on a trading residential care home, sized on stabilised trading profit (EBITDARM). Leverage reflects the operator covenant, the CQC rating (currently Good), occupancy and the fee mix. We shortlist the lenders most likely to back a home of this profile.
Who operates Fairmead House?
Fairmead House is operated by Elysium Healthcare (Ann House) Limited. You can see the operator's wider portfolio, bed stock and rating profile on our operator page. The operator's covenant is central to how any acquisition or refinance of this home is underwritten.
Source: Care Quality Commission care directory, 03 June 2026. Contains public sector information licensed under the Open Government Licence v3.0. Registration and bed data only; this page is care home finance information and is not affiliated with, or endorsed by, Fairmead House or Elysium Healthcare (Ann House) Limited. View the official CQC profile: cqc.org.uk.
Buying, refinancing or developing Fairmead House?
Send us the home and the operator and we will come back with a view on fundability and likely terms within one working day.